Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke;Kis dózisú acetil-szalicilát hatásosan gátolja a thrombocytaaggregatiót ischaemiás stroke után.

Orvosi hetilap

Volumn 137, Issue 9, 1996, Pages 455-459

  Olah L ^a   Misz, M ^a   Bereczki, D ^a   Fekete, I ^a   Bordanne J E ^a   Takacs E I ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; PROSTAGLANDIN F; THROMBOXANE A2; THROMBOXANE B2;

AGED; ARTICLE; BLOOD; BLOOD CLOTTING TEST; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; THROMBOCYTE AGGREGATION;

AGED; AGED, 80 AND OVER; ASPIRIN; BLOOD COAGULATION TESTS; BRAIN ISCHEMIA; CEREBROVASCULAR DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDINS F; THROMBOXANE A2; THROMBOXANE B2;

EID: 18244414225     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)